Cliff Asness's PRAX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 28,828 shares of Praxis Precision Medicines, Inc. (PRAX) worth $8.5 M, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in PRAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 25,268 shares. Largest reduction occurred in Q4 2024, reducing 18,564 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Praxis Precision Medicines (PRAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Praxis Precision Medicines (PRAX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +6,924 | Add 31.61% | 28,828 | $294.74 |
| Q3 2025 | +7,324 | Add 50.23% | 21,904 | $53.00 |
| Q2 2025 | +14,580 | New Buy | 14,580 | $42.05 |
| Q1 2025 | -6,704 | Sold Out | 0 | $0.00 |
| Q4 2024 | -18,564 | Reduce 73.47% | 6,704 | $76.96 |
| Q3 2024 | +25,268 | New Buy | 25,268 | $57.54 |
| Q2 2023 | -4,973 | Sold Out | 0 | $0.00 |
| Q1 2023 | -5,729 | Reduce 53.53% | 4,973 | $12.13 |
| Q4 2022 | -6,081 | Reduce 36.23% | 10,702 | $35.70 |
| Q3 2022 | +15,623 | Add 1346.81% | 16,783 | $34.02 |
| Q2 2022 | +1,160 | New Buy | 1,160 | $37.07 |
Cliff Asness's Praxis Precision Medicines Investment FAQs
Cliff Asness first purchased Praxis Precision Medicines, Inc. (PRAX) in Q2 2022, acquiring 1,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Praxis Precision Medicines, Inc. (PRAX) for 11 quarters since Q2 2022.
Cliff Asness's largest addition to Praxis Precision Medicines, Inc. (PRAX) was in Q3 2024, adding 25,268 shares worth $1.45 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 28,828 shares of Praxis Precision Medicines, Inc. (PRAX), valued at approximately $8.5 M.
As of the Q4 2025 filing, Praxis Precision Medicines, Inc. (PRAX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Praxis Precision Medicines, Inc. (PRAX) was 28,828 shares, as reported at the end of Q4 2025.